Blog

Explore the latest blog from QUAD A.

According to an analysis of the UK’s cosmetic injectables industry by UCL researchers, 68% of cosmetic practitioners who are administering

At QUAD A, we strive to put patients’ needs at the forefront of everything we do. It’s simple, really. We

In our unwavering commitment to prioritizing patient safety, we are revising our follow-up survey process. Historically, we have conducted follow-up

At the first World Health Assembly in 1948, the World Health Organization (WHO) decided to designate a day as “World

The Medical Board of California has made significant strides in combatting the opioid crisis and prioritizing patient safety. Their recently

HIGHLAND PARK, IL – QUAD A recently announced the release of the Centers for Medicare & Medicaid Services (CMS) report

HIGHLAND PARK, IL – QUAD A, the Global Accreditation Authority, announces Randi Hamilton as our newly appointed Director of Marketing.

QUAD A’s mission is to elevate Ambulatory Surgery Centers (ASCs) in delivering exceptional patient care. Therefore, we are pleased to

By: M. Rossiter, D. Zargaran, A. Zargaran, T. Terranova, W. Rosenblatt, S. Hamilton, A. Mosahebi

On 6/05/23, the Centers for Medicare & Medicaid Services (CMS) published a final rule which ends the requirements related to Staff Vaccination

1 – INTRODUCTION The proliferation of providers and practitioners of cosmetic botulinum toxin and dermal filler has profound public health

The United Kingdom’s injectables market is experiencing rapid growth, but the lack of robust regulation has raised concerns. QUAD A’s